Venlafaxine HCL ER
Capsule, extended release · Oral · Prescription
Boxed warning
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older [see Warnings and Precautions ( 5.1)]. In patients of all ages who are started on antidepressant therapy monitor closely for clinical worsening and emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber [see Warnings and Precautions ( 5.1) and Patient Counseling Information ( 17)].
…
Uses
1.1 Major Depressive Disorder
Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder (MDD). Efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials.
1.2 Generalized Anxiety Disorder
Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Generalized Anxiety Disorder (GAD). Efficacy was established in two 8-week and two 26-week placebo-controlled trials.
1.3 Social Anxiety Disorder
Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Social Anxiety Disorder (SAD), also known as social phobia. Efficacy was established in four 12-week and one 26-week, placebo-controlled trials.
1.4 Panic Disorder
Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of Panic Disorder (PD), with or without agoraphobia. Efficacy was established in two 12-week placebo-controlled trials.
From the FDA label of Advanced Rx Pharmacy Of Tennessee LLC, version of Dec 31, 2024. Not medical advice: ask your doctor or pharmacist.
Active ingredient
- Venlafaxine hydrochloride
Generic name
- Venlafaxine HCL
- Venlafaxine HCL ER
Drug class
- Norepinephrine Uptake Inhibitors
- Serotonin Uptake Inhibitors
- Serotonin and Norepinephrine Reuptake Inhibitor
What it looks like
| Imprint | Look | Manufacturer |
|---|---|---|
| E 73 | Gray and Orange, Capsule, 16 mm | Direct_Rx |
| E 74 | Orange, Capsule, 19 mm | Direct_Rx |
| V 11 | White and Orange, Capsule, 21 mm | Advanced Rx Pharmacy Of Tennessee LLC |
Inactive ingredients and allergens
- Gelatin: all 2 products
- Direct_Rx, 37.5 mg/1: ferrosoferric oxide, shellac, ferric oxide red, ethylcellulose (20 mpa.s), hypromellose 2910 (5 mpa.s), talc, gelatin, unspecified, starch, corn, titanium dioxide, sodium lauryl sulfate, sucrose
- Direct_Rx, 75 mg/1: ethylcellulose (20 mpa.s), titanium dioxide, sucrose, starch, corn, hypromellose 2910 (5 mpa.s), ferric oxide red, sodium lauryl sulfate, ferrosoferric oxide, gelatin, unspecified, talc, shellac
From each product's FDA label; they differ between manufacturers and strengths. The app shows every product and finds those without an allergen.
Brand and generics
- Effexor XR Capsule, extended release
- Venlafaxine hydrochloride Capsule, extended release
- Venlafaxine hydrochloride ER Capsule, extended release
Same ingredient and dosage form in the FDA Orange Book; ask a pharmacist before switching.
Official FDA label
- Advanced Rx Pharmacy Of Tennessee LLC on DailyMed, version of Dec 31, 2024
- Direct_Rx on DailyMed, version of Jan 22, 2025
- Direct_Rx on DailyMed, version of Mar 6, 2026
Read the full label as text, with its contents and search, in the app.
Data: FDA NDC Directory, DailyMed labels, Orange Book, Purple Book and Enforcement Reports, updated Nov 17, 2026.